Article Type
Changed
Mon, 02/25/2019 - 04:00

Consider enteral therapy in Crohn’s disease, with caveats. A lawsuit against ABIM draws $200,000 in donation support. A combination model predicts imminent preeclampsia. And the FDA wants more safety data on 12 sunscreen active ingredients.
Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

Publications
Sections

Consider enteral therapy in Crohn’s disease, with caveats. A lawsuit against ABIM draws $200,000 in donation support. A combination model predicts imminent preeclampsia. And the FDA wants more safety data on 12 sunscreen active ingredients.
Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

Consider enteral therapy in Crohn’s disease, with caveats. A lawsuit against ABIM draws $200,000 in donation support. A combination model predicts imminent preeclampsia. And the FDA wants more safety data on 12 sunscreen active ingredients.
Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

Publications
Publications
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica